Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)-A randomized controlled trial of therapeutic drug monitoring and adherence support
Article Abstract:
The feasibility and effectiveness of therapeutic drug monitoring (TDM) and adherence support (collectively, AT) versus standard of care (SOC) in patients receiving HIV protease inhibitors (PIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) within a nurse- led clinic is evaluated. The pharmacologic optimization of PIs and NNRTIs (POPIN) study confirms that TDM trials are complex to interpret and statistically underpowered, with effectiveness better assessed through the clinical utility of a TDM result, whether normal or abnormal.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: Implications for once-daily dosing
Article Abstract:
Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) is a prime focus for developing once-daily therapies primarily as they form the backbone of most existing regimens. Clinicians require an understanding of the plasma and intracellular pharmacokinetics properties of NRTIs to construct simplified and effective therapies for individual patients.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy - Naive HIV-infected patients
Article Abstract:
The study is conducted to analyze the safety and effectiveness of abacavir, lamivudine, and zidovudine (ABC/3TC/ZDV) in antiretroviral therapy (ART)-naive HIV-infected patients. The triple-nucleoside regimen of (ABC/3TC/ZDV) is a reasonable option for ART-naive patients with a plasma HIV-1 viral load (pVL) <100,000 copies/mL.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Surgery for genitourinary prolapse and stress incontinence: a randomized trial of posterior pubourethral ligament plication and Pereyra suspension
- Abstracts: A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
- Abstracts: Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. part 2
- Abstracts: Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. Effects of HIV protease inhibitor ritonavir on vasomotor function and endothelial nitric oxide synthase expression
- Abstracts: Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: A pilot study